European Hepatocyte Users Workshop

Published: 19-Aug-2011

11 October 2011
Workshop
Brussels, Belgium

The workshop is designed for industry professionals seeking to improve hepatocyte handling skills and increase knowledge of in vitro assays for metabolism, inhibition, induction and transporters. Delegates will receive training and best practice skills from experienced Celsis IVT scientists. The laboratory sessions include proper thawing and plating procedures for cryoplateable human hepatocytes and thawing of LiverPool hepatocytes

Organiser: Celsis IVT

Trending Articles

  1. ASGCT Annual Meeting 2024 7-11 May, 2024 | Meeting | Portland, OR
  2. CPhI North America 7-9 May 2024 | Exhibition | Pennsylvania, US
  3. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  4. CPhI Worldwide 2011 <b>25 - 27 October 2011</b><br> Messe Frankfurt
  5. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany

You may also like

Research & Development

Charles River launches Rep/Cap plasmids to streamline adeno-associated viral vector manufacturing

Off-the-shelf Rep/Cap simplifies gene therapy supply chains with immediate availability
Research & Development

CELLphenomics and Charles River to expand 3D in vitro services for cancer therapy drug screening

CELLphenomics’ PD3D tumour model platform will expand Charles River’s portfolio of 3D in vitro testing services
Manufacturing

Multiply Labs' robotic pharmaceutical manufacturing project reaches proof-of-concept

The consortium which contains Multiply Labs, Thermo Fisher, Cytiva, UCSF and Charles River has reached proof-of-concept on a robotic and automated cell manufacturing system
Manufacturing

Charles River announces plasmid manufacturing collaboration with Fondazione Telethon

The two companies have agreed on a manufacturing collaboration that will produce pDNA, used to produce GMP lentivirus for ex vivo gene therapy
Manufacturing

Wheeler Bio welcomes Charles River's biologics lab at manufacturing facility

Deployed on-site at a client’s facility, Charles River helps implement a flexible biologics testing lab
Manufacturing

Charles River and Cure AP-4 collaborate on gene therapy

The company is set to perform HQ plasmid production in support of Phase I/II clinical trials for AP-4 Hereditary Spastic Paraplegia
Manufacturing

Charles River opens plasmid DNA centre of excellence

The expansion follows Charles River's acquisition of Cognate BioServices and Cobra Biologics, a pioneering plasmid DNA, viral vector, and cell therapy CDMO in March 2021
Subscribe now